HIV-1 envelope glycoproteins induce activation of activated protein-1 in CD4+ T cells

N. Chirmule, H. Goonewardena, Savita G Pahwa, R. Pasieka, V. S. Kalyanaraman, S. Pahwa

Research output: Contribution to journalArticle

46 Citations (Scopus)

Abstract

Activation of CD4 positive T cells is a primary requirement for human immunodeficiency virus (HIV) entry, efficient HIV replication, and progression to AIDS. Utilizing CD4 positive T cell lines and purified T cells from normal individuals, we have demonstrated that native envelope glycoproteins of HIV, gp160, can induce activation of transcription factor, activated protein-1 (AP-1). The stimulatory effects of gp160 are mediated through the CD4 molecule, since treatment of gp160 with soluble CD4-IgG abrogates its activity, and CD4 negative T cell lines fail to be stimulated with gp160. Immunoprecipitation of the gp160-induced nuclear extracts with polyclonal antibodies to Fos and Jun proteins indicates that AP-1 complex is comprised of members of these family of proteins. The gp160-induced AP-1 complex is dependent upon protein tyrosine phosphorylation and is protein synthesis-independent. This stimulation can also be abolished by inhibitors of protein kinase C, but it is unaffected by calcium channel blocker or cyclosporine A. This gp160 treatment adversely affects the functional capabilities of T cells; pretreatment of CD4+ T cells with gp160 for 4 h at 37 °C inhibited anti-CD3-induced interleukin-2 secretion. Effects similar to gp160 were seen with anti-CD4 mAb. The aberrant activation of AP-1 by gp160 in CD4 positive T cells could result in up-regulation of cytokines containing AP-1 sites, e.g. interleukin-3 and granulocyte macrophage colony-stimulating factor, and concurrently lead to T cell unresponsiveness by inhibiting interleukin-2 secretion.

Original languageEnglish
Pages (from-to)19364-19369
Number of pages6
JournalJournal of Biological Chemistry
Volume270
Issue number33
DOIs
StatePublished - Jan 1 1995
Externally publishedYes

Fingerprint

T-cells
Viruses
HIV-1
Glycoproteins
Chemical activation
T-Lymphocytes
Proteins
HIV
Interleukin-2
CD4 Immunoadhesins
Cell Line
Virus Internalization
CD4 Antigens
Phosphorylation
Interleukin-3
Calcium Channel Blockers
Granulocyte-Macrophage Colony-Stimulating Factor
Virus Replication
Immunoprecipitation
Protein Kinase C

ASJC Scopus subject areas

  • Biochemistry

Cite this

HIV-1 envelope glycoproteins induce activation of activated protein-1 in CD4+ T cells. / Chirmule, N.; Goonewardena, H.; Pahwa, Savita G; Pasieka, R.; Kalyanaraman, V. S.; Pahwa, S.

In: Journal of Biological Chemistry, Vol. 270, No. 33, 01.01.1995, p. 19364-19369.

Research output: Contribution to journalArticle

Chirmule, N, Goonewardena, H, Pahwa, SG, Pasieka, R, Kalyanaraman, VS & Pahwa, S 1995, 'HIV-1 envelope glycoproteins induce activation of activated protein-1 in CD4+ T cells', Journal of Biological Chemistry, vol. 270, no. 33, pp. 19364-19369. https://doi.org/10.1074/jbc.270.33.19364
Chirmule, N. ; Goonewardena, H. ; Pahwa, Savita G ; Pasieka, R. ; Kalyanaraman, V. S. ; Pahwa, S. / HIV-1 envelope glycoproteins induce activation of activated protein-1 in CD4+ T cells. In: Journal of Biological Chemistry. 1995 ; Vol. 270, No. 33. pp. 19364-19369.
@article{25254c6f38ca482ea967cf2f3adfc1f6,
title = "HIV-1 envelope glycoproteins induce activation of activated protein-1 in CD4+ T cells",
abstract = "Activation of CD4 positive T cells is a primary requirement for human immunodeficiency virus (HIV) entry, efficient HIV replication, and progression to AIDS. Utilizing CD4 positive T cell lines and purified T cells from normal individuals, we have demonstrated that native envelope glycoproteins of HIV, gp160, can induce activation of transcription factor, activated protein-1 (AP-1). The stimulatory effects of gp160 are mediated through the CD4 molecule, since treatment of gp160 with soluble CD4-IgG abrogates its activity, and CD4 negative T cell lines fail to be stimulated with gp160. Immunoprecipitation of the gp160-induced nuclear extracts with polyclonal antibodies to Fos and Jun proteins indicates that AP-1 complex is comprised of members of these family of proteins. The gp160-induced AP-1 complex is dependent upon protein tyrosine phosphorylation and is protein synthesis-independent. This stimulation can also be abolished by inhibitors of protein kinase C, but it is unaffected by calcium channel blocker or cyclosporine A. This gp160 treatment adversely affects the functional capabilities of T cells; pretreatment of CD4+ T cells with gp160 for 4 h at 37 °C inhibited anti-CD3-induced interleukin-2 secretion. Effects similar to gp160 were seen with anti-CD4 mAb. The aberrant activation of AP-1 by gp160 in CD4 positive T cells could result in up-regulation of cytokines containing AP-1 sites, e.g. interleukin-3 and granulocyte macrophage colony-stimulating factor, and concurrently lead to T cell unresponsiveness by inhibiting interleukin-2 secretion.",
author = "N. Chirmule and H. Goonewardena and Pahwa, {Savita G} and R. Pasieka and Kalyanaraman, {V. S.} and S. Pahwa",
year = "1995",
month = "1",
day = "1",
doi = "10.1074/jbc.270.33.19364",
language = "English",
volume = "270",
pages = "19364--19369",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "33",

}

TY - JOUR

T1 - HIV-1 envelope glycoproteins induce activation of activated protein-1 in CD4+ T cells

AU - Chirmule, N.

AU - Goonewardena, H.

AU - Pahwa, Savita G

AU - Pasieka, R.

AU - Kalyanaraman, V. S.

AU - Pahwa, S.

PY - 1995/1/1

Y1 - 1995/1/1

N2 - Activation of CD4 positive T cells is a primary requirement for human immunodeficiency virus (HIV) entry, efficient HIV replication, and progression to AIDS. Utilizing CD4 positive T cell lines and purified T cells from normal individuals, we have demonstrated that native envelope glycoproteins of HIV, gp160, can induce activation of transcription factor, activated protein-1 (AP-1). The stimulatory effects of gp160 are mediated through the CD4 molecule, since treatment of gp160 with soluble CD4-IgG abrogates its activity, and CD4 negative T cell lines fail to be stimulated with gp160. Immunoprecipitation of the gp160-induced nuclear extracts with polyclonal antibodies to Fos and Jun proteins indicates that AP-1 complex is comprised of members of these family of proteins. The gp160-induced AP-1 complex is dependent upon protein tyrosine phosphorylation and is protein synthesis-independent. This stimulation can also be abolished by inhibitors of protein kinase C, but it is unaffected by calcium channel blocker or cyclosporine A. This gp160 treatment adversely affects the functional capabilities of T cells; pretreatment of CD4+ T cells with gp160 for 4 h at 37 °C inhibited anti-CD3-induced interleukin-2 secretion. Effects similar to gp160 were seen with anti-CD4 mAb. The aberrant activation of AP-1 by gp160 in CD4 positive T cells could result in up-regulation of cytokines containing AP-1 sites, e.g. interleukin-3 and granulocyte macrophage colony-stimulating factor, and concurrently lead to T cell unresponsiveness by inhibiting interleukin-2 secretion.

AB - Activation of CD4 positive T cells is a primary requirement for human immunodeficiency virus (HIV) entry, efficient HIV replication, and progression to AIDS. Utilizing CD4 positive T cell lines and purified T cells from normal individuals, we have demonstrated that native envelope glycoproteins of HIV, gp160, can induce activation of transcription factor, activated protein-1 (AP-1). The stimulatory effects of gp160 are mediated through the CD4 molecule, since treatment of gp160 with soluble CD4-IgG abrogates its activity, and CD4 negative T cell lines fail to be stimulated with gp160. Immunoprecipitation of the gp160-induced nuclear extracts with polyclonal antibodies to Fos and Jun proteins indicates that AP-1 complex is comprised of members of these family of proteins. The gp160-induced AP-1 complex is dependent upon protein tyrosine phosphorylation and is protein synthesis-independent. This stimulation can also be abolished by inhibitors of protein kinase C, but it is unaffected by calcium channel blocker or cyclosporine A. This gp160 treatment adversely affects the functional capabilities of T cells; pretreatment of CD4+ T cells with gp160 for 4 h at 37 °C inhibited anti-CD3-induced interleukin-2 secretion. Effects similar to gp160 were seen with anti-CD4 mAb. The aberrant activation of AP-1 by gp160 in CD4 positive T cells could result in up-regulation of cytokines containing AP-1 sites, e.g. interleukin-3 and granulocyte macrophage colony-stimulating factor, and concurrently lead to T cell unresponsiveness by inhibiting interleukin-2 secretion.

UR - http://www.scopus.com/inward/record.url?scp=0029118573&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029118573&partnerID=8YFLogxK

U2 - 10.1074/jbc.270.33.19364

DO - 10.1074/jbc.270.33.19364

M3 - Article

C2 - 7642615

AN - SCOPUS:0029118573

VL - 270

SP - 19364

EP - 19369

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 33

ER -